Fixed drug ratios for treatment of hematopoietic cancers and...

Details Fixed drug ratios for treatment of hematopoietic cancers and... Fixed drug ratios for treatment of hematopoietic cancers and...

A - Human Necessities

61

K

A61K 31/7068 (2006.01) A61K 31/704 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2678332

Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.

Cette invention a trait à des procédés de traitement du cancer en administrant une composition pharmaceutique comprenant un rapport molaire fixe non antagoniste de cytarabine et une anthracycline. Ces procédés sont particulièrement utiles dans le traitement des patients atteints de cancers hématologiques avancés ou d'affections prolifératives.

Affiliated with

Also associated with

Rating

Fixed drug ratios for treatment of hematopoietic cancers and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fixed drug ratios for treatment of hematopoietic cancers and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fixed drug ratios for treatment of hematopoietic cancers and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1912758